Germline findings in cancer predisposing genes from a small cohort of chordoma patients
Journal of Cancer Research and Clinical Oncology · 2024
DOI: 10.1007/s00432-024-05706-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, 2024. Verfasst von Margarita Raygada und 14 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. Raygadam@mail.nih.gov. Hauptthemen laut MEDLINE: Chordoma, Germ-Line Mutation, Genetic Predisposition to Disease, Fetal Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Cancer Institute.
Abstract (Originalsprache)
Introduction
Chordoma is a rare slow-growing tumor that occurs along the length of the spinal axis and arises from primitive notochordal remnants (Stepanek et al., Am J Med Genet 75:335–336, 1998). Most chordomas are sporadic, but a small percentage of cases are due to hereditary cancer syndromes (HCS) such as tuberous sclerosis 1 and 2 ( TSC1/2 ), or constitutional variants in the gene encoding brachyury T ( TBXT ) (Pillay et al., Nat Genet 44:1185–1187, 2012; Yang et al., Nat Genet 41:1176–1178, 2009).
Purpose
The genetic susceptibility of these tumors is not well understood; there are only a small number of studies that have performed germline genetic testing in this population.
Methods
We performed germline genetic in chordoma patients using genomic DNA extracted by blood or saliva.
Conclusion
We report here a chordoma cohort of 24 families with newly found germline genetic mutations in cancer predisposing genes. We discuss implications for genetic counseling, clinical management, and universal germline genetic testing for cancer patients with solid tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. Raygadam@mail.nih.gov.
- NIH Clinical Center (Building 10), 10 Center Drive, Room 1-3750, Bethesda, MD, 20892, USA. Raygadam@mail.nih.gov.
- Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
- Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
- Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. maryfrances.wedekindmalone@nih.gov.
Förderung
- National Cancer Institute
Zitieren
APA
Raygada, M., John, L., Liu, A., Schultz, J., Thomas, B. J., Bernstein, D., Miettinen, M., Raffeld, M., Xi, L., Tyagi, M., Aldape, K., Glod, J., Reilly, K. M., Widemann, B. C., & Wedekind, M. F. (2024). Germline findings in cancer predisposing genes from a small cohort of chordoma patients. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-024-05706-5
Vancouver
Raygada M, John L, Liu A, Schultz J, Thomas BJ, Bernstein D, et al. Germline findings in cancer predisposing genes from a small cohort of chordoma patients. Journal of Cancer Research and Clinical Oncology. 2024. doi:10.1007/s00432-024-05706-5
BibTeX
@article{Raygada2024,
author = {Raygada, Margarita and John, Liny and Liu, Anne and Schultz, Julianne and Thomas, B J and Bernstein, Donna and Miettinen, Markku and Raffeld, Mark and Xi, Liqiang and Tyagi, Manoj and Aldape, Kenneth and Glod, John and Reilly, Karlyne M and Widemann, Brigitte C and Wedekind, Mary Frances},
title = {Germline findings in cancer predisposing genes from a small cohort of chordoma patients},
journal = {Journal of Cancer Research and Clinical Oncology},
year = {2024},
doi = {10.1007/s00432-024-05706-5}
}
EUVIMED